PCM
ACHV icon

Prelude Capital Management’s Achieve Life Sciences ACHV Stock Holding History

Prelude Capital Management’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-25,429
Closed -$109K – 1104
2023
Q3 		$109K Sell
25,429
-1,563
-6% -$7.88K 0.01% 983
2023
Q2 		$140K Buy
26,992
+11,772
+77% +$82.6K 0.01% 894
2023
Q1 		$103K Buy
15,220
+3,375
+28% +$16K 0.01% 949
2022
Q4 		$29K Sell
11,845
-1,316
-10% -$3.38K ﹤0.01% 1161
2022
Q3 		$43K Buy
13,161
+3,053
+30% +$14.6K ﹤0.01% 1241
2022
Q2 		$49K Buy
+10,108
New +$68.6K ﹤0.01% 1482
2017
Q3 		– Sell
-3
Closed -$2K – 1586
2017
Q2 		$2K Sell
3
-7
-70% -$5.67K ﹤0.01% 1519
2017
Q1 		$9K Buy
10
+6
+150% +$7.29K ﹤0.01% 1365
2016
Q4 		$4K Buy
4
+1
+33% +$988 ﹤0.01% 1450
2016
Q3 		$3K Buy
3
+1
+50% +$1.59K ﹤0.01% 1514
2016
Q2 		$5K Buy
+2
New +$4.18K ﹤0.01% 1454
2015
Q1 		– Sell
-2
Closed -$11K – 1906
2014
Q4 		$11K Hold
2
– – ﹤0.01% 1794
2014
Q3 		$12K Hold
2
– – ﹤0.01% 1780
2014
Q2 		$17K Hold
2
– – ﹤0.01% 1748
2014
Q1 		$39K Buy
2
+1
+100% +$24.6K 0.01% 1387
2013
Q4 		$17K Hold
1
– – ﹤0.01% 1366
2013
Q3 		$18K Sell
1
-1
-50% -$20.7K ﹤0.01% 1226
2013
Q2 		$49K Buy
+2
New +$44.7K 0.01% 827

Other funds holding ACHV

SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Prelude Capital Management's ACHV Position: Q4 2023 in Review

Prelude Capital Management sold out of Achieve Life Sciences (ACHV) in Q4 2023, closing a stake of 25,429 shares — an estimated $109K sold.

Prelude Capital Management first reported a position in ACHV in Q2 2013 and held it in 18 quarters. The position peaked at $140K in Q2 2023. 30 funds tracked by Wall St. Rank hold ACHV as of Q4 2023.

  • Prelude Capital Management reported no remaining Achieve Life Sciences position as of Q4 2023 after selling out during the quarter.
  • Prelude Capital Management sold 25,429 Achieve Life Sciences shares in Q4 2023, an estimated $109K.
  • Prelude Capital Management first reported a position in Achieve Life Sciences in Q2 2013 and held it in 18 quarters.
  • Prelude Capital Management's Achieve Life Sciences position peaked at $140K in Q2 2023.
  • 30 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q4 2023.

Based on Prelude Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.